Curaleaf Holdings Files 6-K with July Press Release
Ticker: CURLF · Form: 6-K · Filed: Jul 9, 2024 · CIK: 1756770
| Field | Detail |
|---|---|
| Company | Curaleaf Holdings, Inc. (CURLF) |
| Form Type | 6-K |
| Filed Date | Jul 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, press-release
Related Tickers: CURA
TL;DR
Curaleaf (CURA) filed a 6-K on 7/9, including a 7/3 press release. Legal Officer Peter Clateman signed off.
AI Summary
Curaleaf Holdings, Inc. filed a Form 6-K on July 9, 2024, reporting for the month of July 2024. The filing includes a press release dated July 3, 2024, as Exhibit 99.1. Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc. on July 8, 2024.
Why It Matters
This filing indicates ongoing reporting and communication from Curaleaf Holdings, Inc. to the SEC, potentially including important business updates via the attached press release.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves as a reporting mechanism and includes a press release, with no immediate financial or operational disclosures that suggest high risk.
Key Players & Entities
- Curaleaf Holdings, Inc. (company) — Registrant
- Peter Clateman (person) — Chief Legal Officer
- July 3, 2024 (date) — Press Release Date
- July 8, 2024 (date) — Report Signature Date
- July 9, 2024 (date) — Filing Date
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report information that Curaleaf Holdings, Inc. has made or is required to make public in Canada or the United States, and has filed or made public elsewhere, for the month of July 2024, including an attached press release.
What is included as an exhibit in this filing?
Exhibit 99.1, a Press Release dated July 3, 2024, is included as an exhibit in this filing.
Who signed the report on behalf of Curaleaf Holdings, Inc. and what is their title?
Peter Clateman, Chief Legal Officer, signed the report on behalf of Curaleaf Holdings, Inc.
On what date was this Form 6-K report signed?
The report was signed on July 8, 2024.
What is Curaleaf Holdings, Inc.'s principal executive office address?
Curaleaf Holdings, Inc.'s principal executive offices are located at 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Canada.
Filing Stats: 149 words · 1 min read · ~1 pages · Grade level 10.8 · Accepted 2024-07-08 17:31:45
Filing Documents
- tm2418992d1_6k.htm (6-K) — 10KB
- tm2418992d1_ex99-1.htm (EX-99.1) — 12KB
- 0001104659-24-078358.txt ( ) — 23KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2024. Commission File Number: 333-249081 CURALEAF HOLDINGS, INC. (Exact Name of Registrant as Specified in Charter) 666 Burrard Street, Suite 1700, Vancouver, British Columbia V6C 2X8 Canada (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CURALEAF HOLDINGS, INC. (Registrant) Date: July 8, 2024 By: /s/ Peter Clateman Name: Peter Clateman Title: Chief Legal Officer EXHIBIT INDEX 99.1 Press Release dated July 3, 2024